A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.

Clifford DB, Simpson DM, Brown S, Moyle G, Brew BJ, Conway B, Tobias JK, Vanhove GF. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr. 2012 Feb 01; 59(2):126-33.

View in: PubMed

subject areas

Administration, Cutaneous
Adult
Analgesics, Non-Narcotic
Antipruritics
Capsaicin
Double-Blind Method
Female
Foot Diseases
HIV Infections
Humans
Male
Middle Aged
Neuralgia
Pain Measurement
Polyneuropathies

authors with profiles

Dominic Chow, MD, PhD, MPH

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support